However, studies of SHIP1 KO mice and/or pulsatile SHIPi treated mice suggests there is also the potential to improve dendritic cell function in cancer [99,113] and bias the tumor macrophage compartment toward more inflammatory and phagocytic cells to further facilitate immune control [119,120,121]. The gene discussed is INPP5D; the disease is cancer.